NO20014101D0 - Stabilisert oral farmasoytisk blanding inneholdende iodid og iodat og fremgangsmate - Google Patents

Stabilisert oral farmasoytisk blanding inneholdende iodid og iodat og fremgangsmate

Info

Publication number
NO20014101D0
NO20014101D0 NO20014101A NO20014101A NO20014101D0 NO 20014101 D0 NO20014101 D0 NO 20014101D0 NO 20014101 A NO20014101 A NO 20014101A NO 20014101 A NO20014101 A NO 20014101A NO 20014101 D0 NO20014101 D0 NO 20014101D0
Authority
NO
Norway
Prior art keywords
iodate
pharmaceutical composition
composition containing
oral pharmaceutical
containing iodide
Prior art date
Application number
NO20014101A
Other languages
English (en)
Other versions
NO20014101L (no
Inventor
Yongun Duan
Kirk Dinehart
John Hickey
Jack Kessler
Original Assignee
Symbollon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symbollon Corp filed Critical Symbollon Corp
Publication of NO20014101D0 publication Critical patent/NO20014101D0/no
Publication of NO20014101L publication Critical patent/NO20014101L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20014101A 1999-02-26 2001-08-23 Stabilisert oral farmasöytisk blanding inneholdende iodid og iodat og fremgangsmåte NO20014101L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/258,062 US6248335B1 (en) 1997-10-29 1999-02-26 Stabilized oral pharmaceutical composition containing iodide and iodate and method
PCT/US2000/004411 WO2000050046A1 (en) 1999-02-26 2000-02-22 Stabilized oral pharmaceutical composition containing iodide and iodate and method

Publications (2)

Publication Number Publication Date
NO20014101D0 true NO20014101D0 (no) 2001-08-23
NO20014101L NO20014101L (no) 2001-10-12

Family

ID=22978944

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014101A NO20014101L (no) 1999-02-26 2001-08-23 Stabilisert oral farmasöytisk blanding inneholdende iodid og iodat og fremgangsmåte

Country Status (19)

Country Link
US (1) US6248335B1 (no)
JP (1) JP2002537341A (no)
KR (1) KR100674324B1 (no)
CN (1) CN1344163A (no)
AT (1) AT413795B (no)
AU (1) AU778774B2 (no)
BR (1) BR0008509A (no)
CA (1) CA2366679C (no)
DE (1) DE10084290T1 (no)
DK (1) DK176595B1 (no)
ES (1) ES2226514B2 (no)
FI (1) FI20011703A7 (no)
GB (1) GB2364641B (no)
IL (1) IL144955A (no)
MX (1) MXPA01008550A (no)
NO (1) NO20014101L (no)
SE (1) SE0102843L (no)
WO (1) WO2000050046A1 (no)
ZA (1) ZA200106451B (no)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7147873B2 (en) * 2002-01-16 2006-12-12 3M Innovative Properties Company Antiseptic compositions and methods
US7198653B2 (en) * 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
EP2007225A1 (en) * 2004-12-24 2008-12-31 Council Of Scientific & Industrial Research An improved iodized salt and a process for its preparation
EP1838617B1 (en) * 2005-01-10 2013-07-31 Secretary, Department Of Atomic Energy Calcium potassium ferrocyanide, a prophylactic mixture comprising this compound and the use thereof for decorporation of radiocesium in subjects affected by nuclear radiation
US7943158B2 (en) * 2006-09-07 2011-05-17 BioLargo Life Technologies, Inc Absorbent systems providing antimicrobial activity
US8226964B2 (en) * 2006-09-07 2012-07-24 Biolargo Life Technologies, Inc. Systems and methods for cleaning liquid carriers related applications data
US7867510B2 (en) * 2006-09-07 2011-01-11 BioLargo Life Technologies, Inc Material having antimicrobial activity when wet
US8021610B2 (en) * 2006-09-07 2011-09-20 Biolargo Life Technologies, Inc. Systems providing antimicrobial activity to an environment
US9414601B2 (en) * 2006-09-07 2016-08-16 Biolargo Life Technologies, Incorporated Material having antimicrobial activity when wet
US20080063560A1 (en) * 2006-09-07 2008-03-13 Biolargo Life Technologies, Incorporated Ground treatment for reducing microbial content
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US8257749B2 (en) * 2007-02-08 2012-09-04 Biolargo Life Technologies, Incorporated Systems providing at least pesticidal activity
WO2009087647A1 (en) * 2008-01-07 2009-07-16 Council Of Scientific & Industrial Research A stabilized iodine-water concentrate formulation useful for protection against iodine deficiency disorders
US9622911B2 (en) 2010-09-30 2017-04-18 Cxl Ophthalmics, Llc Ophthalmic treatment device, system, and method of use
EP2830554A1 (en) 2012-03-29 2015-02-04 CXL Ophthalmics, LLC Ocular cross-linking system and method for sealing corneal wounds
EP2830627B1 (en) 2012-03-29 2024-05-01 Epion Therapeutics, Inc. Ocular treatment solutions, delivery devices and delivery augmentation methods
US9566301B2 (en) 2012-03-29 2017-02-14 Cxl Ophthalmics, Llc Compositions and methods for treating or preventing diseases associated with oxidative stress
US10034899B2 (en) 2013-11-27 2018-07-31 BioPharmX, Inc. Solid oral dosage form for breast symptoms
PL3104939T3 (pl) * 2014-02-10 2024-09-30 Fred Hutchinson Cancer Center Leczenie jodkiem sodu zawału serca i urazu niedokrwiennego
US20170304359A1 (en) 2016-04-21 2017-10-26 BioPharmX, Inc. Oral iodine dosage form
JP7516046B2 (ja) 2016-07-21 2024-07-16 アイ２ピュア・コーポレーション エモリエント性の局所消毒剤
WO2018053335A1 (en) * 2016-09-16 2018-03-22 Iogen Llc Oral molecular iodine composition and method
EP3801565A4 (en) * 2018-06-08 2022-04-06 Faraday Pharmaceuticals, Inc. USE OF HALOGENATED COMPOUNDS FOR THE TREATMENT AND PREVENTION OF TISSUE DAMAGE AND POST-INTENSIVE CARE SYNDROME
CN116367845A (zh) 2020-08-13 2023-06-30 I2普乐公司 高浓度分子碘组合物，药物制剂，制备和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4486317A (en) * 1981-01-16 1984-12-04 E. I. Du Pont De Nemours And Company Stabilization of thickened aqueous fluids
RO85156B1 (ro) * 1983-05-27 1984-11-30 Institutul De Stiinte Biologice Comprimate-reactiv pentru determinarea alfa-anilazei si procedeu de obtinere a acestora
CN1036629C (zh) * 1991-03-16 1997-12-10 李克亮 动物促长剂
US5885592A (en) * 1997-10-29 1999-03-23 Symbollon Corporation Methods and pharmaceutical compositions for oral delivery of molecular iodine
CA2317587A1 (en) * 1998-01-06 1999-07-15 Fujisawa Pharmaceutical Co., Ltd. Solid iodophor preparations and process for producing the same
US5985340A (en) * 1998-01-19 1999-11-16 Bolentica, Inc. Method for preparing iodine supplement for animal feeds

Also Published As

Publication number Publication date
US6248335B1 (en) 2001-06-19
WO2000050046A1 (en) 2000-08-31
CA2366679C (en) 2007-05-01
SE0102843L (sv) 2001-10-26
FI20011703L (fi) 2001-10-16
ZA200106451B (en) 2002-08-06
AU3371300A (en) 2000-09-14
SE0102843D0 (sv) 2001-08-27
AU778774B2 (en) 2004-12-23
WO2000050046A8 (en) 2003-11-27
DE10084290T1 (de) 2003-04-03
ES2226514A1 (es) 2005-03-16
ES2226514B2 (es) 2007-02-16
AT413795B (de) 2006-06-15
FI20011703A7 (fi) 2001-10-16
CN1344163A (zh) 2002-04-10
DK176595B1 (da) 2008-10-20
KR100674324B1 (ko) 2007-01-24
NO20014101L (no) 2001-10-12
KR20010103014A (ko) 2001-11-17
CA2366679A1 (en) 2000-08-31
ATA90122000A (de) 2005-10-15
GB0122808D0 (en) 2001-11-14
JP2002537341A (ja) 2002-11-05
MXPA01008550A (es) 2003-08-19
BR0008509A (pt) 2002-02-05
GB2364641A (en) 2002-02-06
IL144955A0 (en) 2002-06-30
IL144955A (en) 2006-12-31
DK200101258A (da) 2001-10-26
GB2364641B (en) 2004-06-30
FI20011703A0 (fi) 2001-08-24

Similar Documents

Publication Publication Date Title
FI20011703L (fi) Jodidia ja jodaattia sisältävä stabiloitu oraalinen farmaseuttinen koostumus sekä menetelmä
NO20021401D0 (no) Konazolinforbindelser og farmasöytiske preparater inneholdende slike forbindelser
DK1206281T3 (da) Formulering indeholdende moxifloxacin og natriumchlorid
DE69634053D1 (de) Oral anzuwendende Arzneizusammensetzung enthaltend 2-Methyl-thienobenzodiazepin
HUP0204372A3 (en) Pharmaceutical compositions providing enhanced drug concentrations
HUP0204580A3 (en) Aryl fused azapolycyclic compounds and pharmaceutical compositions containing them
HUP0200997A3 (en) Tri-aryl acid derivatives as ppar receptor ligands and pharmaceutical compositions containing them
FI964682A7 (fi) Glukagonia sisältävä farmaseuttinen valmiste
HUP0203378A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
NO20014994D0 (no) Hvitt pulver og fremgangsmåte for fremstilling derav
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
DE69827357D1 (de) Menschliches Wachstumshormon enthaltende pharmazeutische Zusammensetzung
HUP0000137A3 (en) Controller-release pharmaceutical composition containing anangetics
NO20034778L (no) Farmasöytiske sammensetninger for oral og topisk anvendelse
DK0981334T3 (da) Slugetabletter indeholdende paracetamol
ITMI921123A0 (it) Formulazioni farmaceutiche orali contenenti antocianosidi
HUP0303184A3 (en) Substituted c-cyclohexylmethylamine derivatives and pharmaceutical compositions containing them
NO308236B1 (no) Farmasøytisk blanding inneholdende indolderivater
HUP0200747A3 (en) Pharmaceutical compounds and pharmaceutical compositions containing them
EE200300135A (et) Trüptamiini derivaadid ja analoogsed ühendid ningneid sisaldavad farmatseutilised preparaadid
DK1005342T3 (da) Farmaceutiske sammensætninger indeholdende tizoxanid og nitazoxanid
HUP0004345A3 (en) Novel oral pharmaceutical compositions containing from carvedilol
DE69910188D1 (de) Arzneiformen enthaltend carvedilol
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application